113 related articles for article (PubMed ID: 6548626)
1. A diphenylmethane derivative selective for the anti-estrogen binding site may help define its biological role.
Brandes LJ
Biochem Biophys Res Commun; 1984 Oct; 124(1):244-9. PubMed ID: 6548626
[TBL] [Abstract][Full Text] [Related]
2. A diphenylmethane derivative specific for the antiestrogen binding site found in rat liver microsomes.
Brandes LJ; Hermonat MW
Biochem Biophys Res Commun; 1984 Sep; 123(2):724-8. PubMed ID: 6548377
[TBL] [Abstract][Full Text] [Related]
3. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.
Brandes LJ; Bogdanovic RP; Cawker MD; LaBella FS
Cancer Res; 1987 Aug; 47(15):4025-31. PubMed ID: 2886214
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the antiestrogen binding site is a histamine or histamine-like receptor.
Brandes LJ; Macdonald LM; Bogdanovic RP
Biochem Biophys Res Commun; 1985 Jan; 126(2):905-10. PubMed ID: 2858205
[TBL] [Abstract][Full Text] [Related]
5. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
6. Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylation.
Brandes LJ; Gerrard JM; Bogdanovic RP; Lint DW; Reid RE; LaBella FS
Cancer Res; 1988 Jul; 48(14):3954-8. PubMed ID: 3164253
[TBL] [Abstract][Full Text] [Related]
7. Study of the in-vivo antioestrogenic action of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine HCl (DPPE), a novel intracellular histamine antagonist and antioestrogen binding site ligand.
Brandes LJ; Hogg GR
J Reprod Fertil; 1990 May; 89(1):59-67. PubMed ID: 2374133
[TBL] [Abstract][Full Text] [Related]
8. Further evidence for a biological role of anti-estrogen-binding sites in mediating the growth inhibitory action of diphenylmethane derivatives.
Fargin A; Bayard F; Faye JC; Traore M; Poirot M; Klaebe A; Perie JJ
Chem Biol Interact; 1988; 66(1-2):101-9. PubMed ID: 3383282
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of tamoxifen and of a tamoxifen analogue that does not bind the estrogen receptor on serum lipid profiles in the cockerel.
Lazier CB; Breckenridge WC
Biochem Cell Biol; 1990 Jan; 68(1):210-7. PubMed ID: 2350488
[TBL] [Abstract][Full Text] [Related]
10. The anti-proliferative properties of 4-benzylphenoxy ethanamine derivatives are mediated by the anti-estrogen binding site (ABS), whereas the anti-estrogenic effects of trifluopromazine are not.
Poirot M; Garnier M; Bayard F; Riviere I; Traore M; Wilson M; Fargin A; Faye JC
Biochem Pharmacol; 1990 Aug; 40(3):425-9. PubMed ID: 2383280
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS).
Poirot M; De Medina P; Delarue F; Perie JJ; Klaebe A; Faye JC
Bioorg Med Chem; 2000 Aug; 8(8):2007-16. PubMed ID: 11003145
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of tamoxifen and analogs with nonbasic side chains on cell proliferation in vitro.
Murphy LC; Sutherland RL
Endocrinology; 1985 Mar; 116(3):1071-8. PubMed ID: 3971898
[TBL] [Abstract][Full Text] [Related]
13. The antiproliferative properties of tamoxifen and phenothiazines may be mediated by a unique histamine receptor (?H3) distinct from the calmodulin-binding site.
Brandes LJ; Bogdanovic RP; Cawker MD; Bose R
Cancer Chemother Pharmacol; 1986; 18(1):21-3. PubMed ID: 3757154
[TBL] [Abstract][Full Text] [Related]
14. Growth-inhibitory effects of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]-ethanamine-HCl combined with cisplatin on human ovarian cancer cells inoculated into nude mice.
Hiramatsu H; Kikuchi Y; Kudoh K; Kita T; Tode T; Nagata I
Jpn J Cancer Res; 1997 Oct; 88(10):1003-8. PubMed ID: 9414663
[TBL] [Abstract][Full Text] [Related]
15. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
Sheen YY; Simpson DM; Katzenellenbogen BS
Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
[TBL] [Abstract][Full Text] [Related]
17. Antiestrogens inhibit the replication of the retroviral Moloney murine leukemia virus in vitro.
Chailleux C; Mesange F; Bayard F; Prats AC; Faye JC
Mol Pharmacol; 1993 Aug; 44(2):324-7. PubMed ID: 7689144
[TBL] [Abstract][Full Text] [Related]
18. Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer.
Toko T; Shibata J; Nukatsuka M; Yamada Y
Cancer Chemother Pharmacol; 1997; 39(5):390-8. PubMed ID: 9054952
[TBL] [Abstract][Full Text] [Related]
19. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
Reddel RR; Murphy LC; Hall RE; Sutherland RL
Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
